ENPP2 and Hepatic fibrosis: Further investigations examining the possible effect of selective ATX inhibitors on inflammation and progression of liver fibrosis in BA are needed for the development of non-transplant therapeutic strategies to prevent the progression of this devastating disease in affected infants.